OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RETRACTED: Hesperidin methylchalcone (HMC) hinders amyloid-β induced Alzheimer's disease by attenuating cholinesterase activity, macromolecular damages, oxidative stress and apoptosis via regulating NF-κB and Nrf2/HO-1 pathways
Zhuo Wang, Chao Gao, Lei Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 233, pp. 123169-123169
Open Access | Times Cited: 10
Zhuo Wang, Chao Gao, Lei Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 233, pp. 123169-123169
Open Access | Times Cited: 10
Showing 10 citing articles:
Heme oxygenase‐1: The roles of both good and evil in neurodegenerative diseases
Rong Liu, Jiahua Yang, Yinghui Li, et al.
Journal of Neurochemistry (2023) Vol. 167, Iss. 3, pp. 347-361
Open Access | Times Cited: 24
Rong Liu, Jiahua Yang, Yinghui Li, et al.
Journal of Neurochemistry (2023) Vol. 167, Iss. 3, pp. 347-361
Open Access | Times Cited: 24
Neurotrophic Natural Products
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2024), pp. 1-473
Closed Access | Times Cited: 5
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2024), pp. 1-473
Closed Access | Times Cited: 5
Natural antioxidants that act against Alzheimer’s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Neuroprotective Role of Phytoconstituents-based Nanoemulsion for the Treatment of Alzheimer’s Disease
Sukriti Vishwas, Bushra Bashir, Devendra Birla, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1683-1698
Closed Access | Times Cited: 3
Sukriti Vishwas, Bushra Bashir, Devendra Birla, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1683-1698
Closed Access | Times Cited: 3
Rutin prevents pyroptosis and M1 microglia via Nrf2/Mac-1/caspase-1-mediated inflammasome axis to improve POCD
Yelong Ji, Yuanyuan Ma, Yimei Ma, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111290-111290
Closed Access | Times Cited: 8
Yelong Ji, Yuanyuan Ma, Yimei Ma, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111290-111290
Closed Access | Times Cited: 8
Rosavin thwarts amyloid-β-induced macromolecular damages and neurotoxicity, exhibiting anti-Alzheimer’s disease activity in Wister rat model
Meiyi Huang, Rubo Sui, Lei Zhang, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1461-1474
Closed Access | Times Cited: 3
Meiyi Huang, Rubo Sui, Lei Zhang, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1461-1474
Closed Access | Times Cited: 3
Integrating serum pharmacochemistry and network pharmacology to reveal the active constituents and mechanism of Corydalis Rhizoma in treating Alzheimer’s disease
Yan Lyu, Yu Wang, Jian‐You Guo, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 2
Yan Lyu, Yu Wang, Jian‐You Guo, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 2
Natural Medicines (Phytoconstituents) and Probiotics as the Future of Alzheimer’s Disease
Sukriti Vishwas, Monica Gulati, Sachin Kumar Singh, et al.
(2024), pp. 397-412
Closed Access
Sukriti Vishwas, Monica Gulati, Sachin Kumar Singh, et al.
(2024), pp. 397-412
Closed Access
The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu, et al.
(2023), pp. 351-376
Closed Access | Times Cited: 1
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu, et al.
(2023), pp. 351-376
Closed Access | Times Cited: 1
2‐Oxoquinoline‐based‐thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors
Rabia Basri, Shamool Fatima, Saquib Jalil, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Open Access | Times Cited: 1
Rabia Basri, Shamool Fatima, Saquib Jalil, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Open Access | Times Cited: 1
Research Progress of Stem Cell Exosomes in Alzheimer’s Disease
良康 古
Bioprocess (2023) Vol. 13, Iss. 02, pp. 91-97
Closed Access
良康 古
Bioprocess (2023) Vol. 13, Iss. 02, pp. 91-97
Closed Access
